Previous close | 11.05 |
Open | 11.05 |
Bid | 10.50 |
Ask | 13.75 |
Strike | 0.50 |
Expiry date | 2025-01-17 |
Day's range | 11.05 - 11.05 |
Contract range | N/A |
Volume | |
Open interest | 6 |
Novavax stock remains volatile. After hitting a two-year high in June on enthusiasm for its updated Covid vaccine, shares have pulled back.
Though Novavax is behind in the COVID-19 vaccine race, a blockbuster deal with Sanofi and a differentiated product means the stock offers the best reward prospects in the industry.
Novavax stock rose on its strong earnings, though sales came in light and the company cut its outlook. Is NVAX stock a buy or a sell?